The antidiabetic medication metformin reduces anxiety-like behaviours in...
> read more
Choosing the right drug to fight cancer
Canadian researchers have just discovered a molecular mechanism that drives cancer progression, providing the possibility for the use of precision medicine whereby patients are matched...
Artificial intelligence provides boost to proteome research
Using artificial intelligence (AI), researchers at the Technical University of Munich (TUM) have developed software to analyse the proteins from any organism significantly faster and...
Pregnancy protein mechanism identified as potential drug target
Researchers at Flinders University, Australia, have discovered the mechanism involved in dealing with biological stresses and associated protein misfolding in pregnant women
Clinical Innovation Partnership set for September, plus get 15% off here
On 11 and 12 of September, Clinical Innovation Partnerships is the only event for senior clinical operations and procurement professionals driving innovation in their clinical trials
Potential new therapy for oesophageal cancer
Researchers at the Medical University of South Carolina (MUSC) have found a way to target drug-resistant oesophageal cancer cells by exploiting the different energy needs of...
Twitter launches new initiative to combat vaccine myths on its platform
Twitter announced this week that it plans to present reliable information about vaccines to help combat misconceptions being spread on the platform
Orphan drugs market to reach $224 billion by 2024
Breakthrough treatments will contribute to a 12% compound annual growth rate for orphan drugs through to 2024, according to a report by Evaluate Pharma.
Deadly measles outbreaks on the rise
Approximately 21 million children worldwide are not having measles vaccinations every year, substantially increasing their risk of raising the risk of the disease later in life.
Throat lozenges could be contributing to antimicrobial resistance
Over the counter (OTC) throat lozenges could be contributing to antimicrobial resistance (AMR) according to research presented at this year's European Congress of Clinical Microbiology...
Half of patients have suboptimal response to statins
Over half of patients who are prescribed statins do not see their cholesterol drop to desired levels within two years, according to research published in the journal Heart.
New laws in China to ensure steady drug supply
China’s National Health Commission (NHC) has stated that it will monitor the country’s drugs market more closely in order to ensure a sufficient supply of essential medicines.
Huge cost of opioid epidemic
New research from Pennsylvania State University has reported that the opioid epidemic may have cost US state and federal governments as much as $37.8 billion in lost tax revenue.
Underwater forests a treasure trove of new drugs
In light of the increasing resistant microbes, researchers are taking their search for drug candidates offshore. A new study published in Frontiers in Microbiology reported that a...
Epilepsy Society calls for review of UK supply chain after increase in access issues
The Epilepsy Society has recently spoken out about the “steep rise” in UK patients experiencing difficulty in accessing seizure medication.
Call for temporary medicines export ban in light of no-deal Brexit outcome
The UK pharma industry has called for a temporary medicines export ban to prevent the NHS from being hit by national drugs shortage in the event of no-deal Brexit.
NHS England’s medicines chief calls for faster market access
NHS England now plays a key gatekeeper role for the industry’s high cost specialised medicines, and has become increasingly commercially savvy over recent years, working alongside...
SHL makes debut at APLAR-ARA 2019
SHL Group will make its first appearance at the 21st Asia Pacific League of Associations for Rheumatology Congress from 8-11 April in Brisbane, Australia. The congress will be held...
UCSF discover potential new treatment approach for type 1 diabetes
Researchers at the University of California, San Francisco (UCSF) Diabetes Centre have uncovered evidence to suggest assumptions about the cause of type 1 diabetes are incorrect,...
Greater Manchester backs move to outcome-based payment
The trend towards paying for medicines based on patient outcomes (OBP) are growing in both the US and Europe